|
1
|
Pan Y, Yuan F, Li Y, Wang G, Lin Z and
Chen L: Bromodomain PHD-finger transcription factor promotes glioma
progression and indicates poor prognosis. Oncol Rep. 41:246–256.
2019.PubMed/NCBI
|
|
2
|
Yan J, Xu C, Li Y, Tang B, Xie S, Hong T
and Zeng E: Long non-coding RNA LINC00526 represses glioma
progression via forming a double negative feedback loop with AXL. J
Cell Mol Med. 23:5518–5531. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo Y, Hong W, Wang X, Zhang P, Körner H,
Tu J and Wei W: MicroRNAs in microglia: How do micrornas affect
activation, inflammation, polarization of microglia and mediate the
interaction between microglia and glioma? Front Mol Neurosci.
12:1252019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Petrescu GED, Sabo AA, Torsin LI, Calin GA
and Dragomir MP: MicroRNA based theranostics for brain cancer:
Basic principles. J Exp Clin Cancer Res. 38:2312019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Si W, Shen J, Zheng H and Fan W: The role
and mechanisms of action of microRNAs in cancer drug resistance.
Clin Epigenetics. 11:252019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Omar HA, El-Serafi AT, Hersi F, Arafa ESA,
Zaher DM, Madkour M, Arab HH and Tolba MF: Immunomodulatory
MicroRNAs in cancer: Targeting immune checkpoints and the tumor
microenvironment. FEBS J. Jul 15–2019.(Epub ahead of print) doi:
10.1111/febs.15000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ye X, Wei W, Zhang Z, He C, Yang R, Zhang
J, Wu Z, Huang Q and Jiang Q: Identification of microRNAs
associated with glioma diagnosis and prognosis. Oncotarget.
8:26394–26403. 2017.PubMed/NCBI
|
|
9
|
Zhang Y, Zhang R, Sui R, Chen Y, Liang H,
Shi J and Piao H: MicroRNA-374a governs aggressive cell behaviors
of glioma by targeting prokineticin 2. Technol Cancer Res Treat.
18:15330338188214012019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barciszewska AM: MicroRNAs as efficient
biomarkers in high-grade gliomas. Folia Neuropathol. 54:369–374.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang HL, Hu AP, Li SL, Xie JP, Ma QZ and
Liu JY: MiR-454 prompts cell proliferation of human colorectal
cancer cells by repressing CYLD expression. Asian Pac J Cancer
Prev. 16:2397–2402. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Piwecka M, Rolle K, Belter A, Barciszewska
AM, Żywicki M, Michalak M, Nowak S, Naskręt-Barciszewska MZ and
Barciszewski J: Comprehensive analysis of microRNA expression
profile in malignant glioma tissues. Mol Oncol. 9:1324–1340. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meyers KT, Marballi KK, Brunwasser SJ,
Renda B, Charbel M, Marrone DF and Gallitano AL: The immediate
early gene Egr3 is required for hippocampal induction of Bdnf by
electroconvulsive stimulation. Front Behav Neurosci. 12:922018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chien MH, Lee WJ, Yang YC, Li YL, Chen BR,
Cheng TY, Yang PW, Wang MY, Jan YH, Lin YK, et al: KSRP suppresses
cell invasion and metastasis through miR-23a-mediated EGR3 mRNA
degradation in non-small cell lung cancer. Biochim Biophys Acta
Gene Regul Mech. 1860:1013–1024. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maple A, Lackie RE, Elizalde DI, Grella
SL, Damphousse CC, Xa C, Gallitano AL and Marrone DF: Attenuated
late-phase Arc transcription in the dentate gyrus of mice lacking
Egr3. Neural Plast. 2017:60630482017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oliveira Fernandes M and Tourtellotte WG:
Egr3-dependent muscle spindle stretch receptor intrafusal muscle
fiber differentiation and fusimotor innervation homeostasis. J
Neurosci. 35:5566–5578. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang S, Xia C, Xu C, Liu J, Zhu H, Yang
Y, Xu F, Zhao J, Chang Y and Zhao Q: Early growth response 3
inhibits growth of hepatocellular carcinoma cells via upregulation
of Fas ligand. Int J Oncol. 50:805–814. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
20
|
Zhang Y, Chen J, Xue Q, Wang J, Zhao L,
Han K, Zhang D and Hou L: Prognostic significance of MicroRNAs in
glioma: A systematic review and meta-analysis. Biomed Res Int.
2019:40159692019.PubMed/NCBI
|
|
21
|
Beadle C, Assanah MC, Monzo P, Vallee R,
Rosenfeld SS and Canoll P: The role of myosin II in glioma invasion
of the brain. Mol Biol Cell. 19:3357–3368. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shao N, Wang L, Xue L, Wang R and Lan Q:
Plasma miR-454-3p as a potential prognostic indicator in human
glioma. Neurol Sci. 36:309–313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kabekkodu SP, Shukla V, Varghese VK, Adiga
D, Vethil Jishnu P, Chakrabarty S and Satyamoorthy K: Cluster
miRNAs and cancer: Diagnostic, prognostic and therapeutic
opportunities. Wiley Interdiscip Rev RNA. e15632019.PubMed/NCBI
|
|
24
|
Wang X, Liu B, Wen F and Song Y:
MicroRNA-454 inhibits the malignant biological behaviours of
gastric cancer cells by directly targeting mitogen-activated
protein kinase 1. Oncol Rep. 39:1494–1504. 2018.PubMed/NCBI
|
|
25
|
Fu Q, Gao Y, Yang F, Mao T, Sun Z, Wang H,
Song B and Li X: Suppression of microRNA-454 impedes the
proliferation and invasion of prostate cancer cells by promoting
N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin
signaling. Biomed Pharmacother. 97:120–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou L, Qu YM, Zhao XM and Yue ZD:
Involvement of miR-454 overexpression in the poor prognosis of
hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 20:825–829.
2016.PubMed/NCBI
|
|
27
|
Zhu DY, Li XN, Qi Y, Liu DL, Yang Y, Zhao
J, Zhang CY, Wu K and Zhao S: MiR-454 promotes the progression of
human non-small cell lung cancer and directly targets PTEN. Biomed
Pharmacother. 81:79–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao ZG, Li JJ, Yao L, Huang YN, Liu YR, Hu
X, Song CG and Shao ZM: High expression of microRNA-454 is
associated with poor prognosis in triple-negative breast cancer.
Oncotarget. 7:64900–64909. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang P, Yang X, Wang L, Zhang D, Luo Q
and Wang B: Overexpressing miR-335 inhibits DU145 cell
proliferation by targeting early growth response 3 in prostate
cancer. Int J Oncol. 54:1981–1994. 2019.PubMed/NCBI
|
|
30
|
Zhu D, He X, Duan Y, Chen J, Wang J, Sun
X, Qian H, Feng J, Sun W, Xu F and Zhang L: Expression of
microRNA-454 in TGF-β1-stimulated hepatic stellate cells and in
mouse livers infected with Schistosoma japonicum. Parasit Vectors.
7:1482014. View Article : Google Scholar : PubMed/NCBI
|
